Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Ilford, United Kingdom Clinical Trials

A listing of Ilford, United Kingdom clinical trials actively recruiting patients volunteers.

RESULTS

Found (6) clinical trials

Advanced MRI for Posterior Fossa Tumours

Post-operative paediatric cerebellar mutism syndrome (pCMS) is a well-recognised complication of resective surgery for brain tumours of the cerebellum and fourth ventricle in children. Occurring in around 25% of infratentorial craniotomies, it is characterised by a delayed onset of mutism and emotional lability, and may comprise motoric and cognitive cerebellar ...

Phase N/A

8.76 miles

Learn More »

Cognitive Bias Modification Training in Adolescents Who Have Experienced Adversity

Up to 160 adolescents aged 12-18 years who have experienced adversity (childhood maltreatment and other forms of broader victimisation experiences) from the United Kingdom (UK), India and Nepal will be randomly allocated to receive a 5-session cognitive bias modification training (with attention and interpretation bias modification modules) or a control ...

Phase N/A

9.3 miles

Learn More »

Imaging 5HT7 Antagonist Effects in Bipolar Disorder

OBJECTIVE Primary To determine the effect of 5HT7 antagonism on cognition related brain activations and cognitive performance in people with bipolar disorder. Secondary To examine the effect of 5HT7 antagonism on emotional processing related brain activations in people with bipolar disorder. To examine the effect of 5HT7 antagonism on behavioral ...

Phase N/A

9.3 miles

Learn More »

Prehabilitation of Patients With oEsophageal Malignancy Undergoing Peri-operative Treatment

Oesophageal cancer has the fastest rising incidence of any solid tumour in the western world with the UK, and London, having particularly high rates of the disease. Those patients being considered for "cure" will benefit from pre-operative/neo-adjuvant chemotherapy (NAC), which is known to have a deleterious effect on fitness and ...

Phase N/A

9.35 miles

Learn More »

TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer

Patients with advanced castration resistant prostate cancer will receive single agent Olaparib at a dose of 400mg twice daily, continuously on a 28 day cycle. Olaparib will be administered until objective disease progression or unacceptable toxicity or patient withdrawal for whatever reason

Phase

9.42 miles

Learn More »

EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer

This is a randomised phase II study comparing the efficacy of avelumab alone with avelumab + cetuximab combination in patients with platinum-resistant advanced or metastatic head & neck cancer. The randomised phase II part of the trial will be preceded by a safety run-in.The objective of the safety run in ...

Phase

9.43 miles

Learn More »